4.61
price down icon8.25%   -0.36
 
loading

Passage Bio Inc Azioni (PASG) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
25.80%
5.418
4.307 5.814 7.737 -
Operating Income/Loss
60.00%
-13.85
-8.655 -10.33 -16.46 -14.27
Income/Loss From Continuing Operations Before Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Income/Loss From Continuing Operations After Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Net Income/Loss
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Diluted Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Basic Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Diluted Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$28.12
price up icon 1.17%
$50.01
price up icon 1.05%
$99.53
price up icon 2.04%
$139.48
price down icon 3.22%
$140.13
price up icon 5.16%
ONC ONC
$296.73
price up icon 1.00%
Capitalizzazione:     |  Volume (24 ore):